Sale
Massive Discounts! Up to 50% OFF on reports🎉

Glioblastoma Multiforme Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Glioblastoma Multiforme Market is segmented By Treatment type (Drugs (Temozolomide, Bevacizumab, Carmustine, Others), Immunotherapy, Electric field therapy, Others), By Type of molecule (Small molecules, Biologics), By Route of administration (Oral, Parenteral), By End-user (Hospitals, Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published: December 2024
SKU : PH2127
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s

Related Reports
pharmaceuticals

Chondrosarcoma Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 December 13
Starting from

$4350

pharmaceuticals

Hepatoblastoma Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 July 18
Starting from

$4350

pharmaceuticals

Adenoid Cystic Carcinoma Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 October 24
Starting from

$4350

pharmaceuticals

Testicular Cancer Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 November 15
Starting from

$4350

pharmaceuticals

Liposarcoma Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 December 18
Starting from

$4350

pharmaceuticals

Germ Cell Tumor Treatment Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2023 November 30
Starting from

$4350